Colfax Corporation

Colfax Corporation

CFX

$39.06

Updated: 24/09/2026, 15:12:13

Market Cap
$2.12B
Sector
Industrials
Industry
Industrial - Machinery
Country
US

No historical data available

Company Profile

Colfax Corporation operates as a global, diversified technology enterprise, structured into two primary divisions: Fabrication Technology and Medical Technology. The Fabrication Technology division specializes in the formulation, development, manufacturing, and supply of consumable products and associated equipment. These are crucial for industrial applications such as cutting, joining, automated welding, and gas flow control. Its comprehensive product portfolio includes a variety of welding consumables, like electrodes, wires, and fluxes, alongside cutting consumables such as nozzles, shields, and tips. These items are distributed through independent channels and direct sales to diverse markets, including general industry, construction, infrastructure, transportation, energy, and medical and life sciences, predominantly under the ESAB brand. Conversely, the Medical Technology division is dedicated to the development, production, and distribution of advanced medical devices. These devices are utilized by a broad spectrum of healthcare practitioners, including orthopedic specialists, surgeons, physical therapists, and athletic trainers, to manage musculoskeletal conditions caused by degenerative diseases, deformities, traumatic incidents, and sports-related injuries. Its extensive product offerings encompass rigid and soft orthopedic bracing, hot and cold therapy systems, bone growth stimulators, vascular therapy solutions, therapeutic footwear, electrical stimulators for pain management, and a full range of reconstructive joint implants for areas like the hip, knee, and shoulder. Sales for this segment, primarily under the DJO brand, occur via independent distributors (such as healthcare professionals and retail pharmacies) and direct channels. Established in 1860, Colfax Corporation is headquartered in Wilmington, Delaware.

USD
NYSE
CEO: Matthew Trerotola
Employees: 16,200
https://www.colfaxcorp.com
Asset Summaries
Latest generated summaries for CFX

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for CFX.
Share price
$39.06
Market cap
$2.12B
Exchange
NYSE
Currency
USD
CEO
Matthew Trerotola
Employees
16,200
IPO date
08/05/2008
Beta
2.122549
Last dividend
$0.00
Day range
$38.88 – $40.67
52-week range
$38.88 – $94.03
1-day performance
-3.77%
1-year performance
0.46%
Current drawdown (1Y)
-58.46%
CIK
0001420800
CUSIP
194014106
ISIN
US1940141062
Created
07/12/2025, 03:16:34
Last update
24/09/2026, 15:12:13

Track Colfax Corporation with an AI analyst

See which prediction-market events move CFX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to CFX from your Railway `news_articles` table.

No news found for this symbol.